- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02584894
Potentiation of Trauma Exposure in Post-traumatic Stress Disorder by Repeated Transcranial Magnetic Stimulation (TETT-STIM)
Potentiation of Trauma Exposure in Post-traumatic Stress Disorder by Repeated Transcranial Magnetic Stimulation : A Control Randomized Study
Study Overview
Status
Conditions
Detailed Description
Post-Traumatic Stress Disorder (PTSD) is characterized by intrusive and persistent memory of past result from an event causing or able to cause death, be a threat of death, a severe injury or constitute a threat for physical integrity. It is a frequent disorder in general population (8%). In France, The most frequent traumatic events causing PTSD are serious accidents, rape, physical assaults, violence, etc. PTSD treatment involves antidepressant and cognitive and behavioural psychotherapy, which encourage exposure to elements that remind the trauma (memories, circumstances), with the objective of reducing the fear associated with the traumatic memories. Innovative therapeutic strategies aim to improve the psychotherapeutic effect with enhancement drugs or using neuromodulatory techniques, such as repeated transcranial magnetic stimulation (rTMS).
The aim of this study is to assess the efficacy in PTSD treatment of concomitant voluntary reactivation of personal traumatic memories with neuromodulation of the right dorsolateral prefrontal cortex using 10Hz rTMS, compared to 1Hz rTMS, during 2 weeks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- PCLS score >40
- Able to give his written informed consent
- Not participating another study
- Affiliation to a social security system
- Having a PTSD for 3 months
- No treatment modification for 4 weeks (Psychotropic treatment or structured psychotherapy)
Exclusion Criteria:
- Partially deaf with equipment
- people with identified neurological disease
- people with addiction to psychoactive substance
- people who can't conform to tests
- people having a contraindication for rTMS (cochlear implant )
- people suffering from chronicle or acute delusional disorder
- any circumstances making the people unable to understood nature, aim or consequences of the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: rTMS 1Hz
Subjects have 8 session of trauma exposure with repeated transcranial magnetic stimulation (rTMS) at 1Hz on dorsolateral prefrontal cortex (1Hz rTMS is describe in the literature to have no effect on the dorsolateral prefrontal cortex).
psychoneurological assessment.
Electrodermal conductance measure With conductivity meter .
Heart rate measure With electrocardiogram
|
trauma exposure + repeated transcranial magnetic stimulation at 1Hz
psychoneurological assessment
electrodermal conductance measure
heart rate measure
|
Experimental: rTMS 10Hz
Subjects have 8 session of trauma exposure with repeated transcranial magnetic stimulation (rTMS) at 10Hz on dorsolateral prefrontal cortex (10Hz rTMS is describe in the literature to have effect on the dorsolateral prefrontal cortex).
psychoneurological assessment.
Electrodermal conductance measure With conductivity meter.
Heart rate measure with electrocardiogram
|
psychoneurological assessment
electrodermal conductance measure
heart rate measure
trauma exposure + repeated transcranial magnetic stimulation at 10Hz
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Score at Clinician administered PTSD scale
Time Frame: inclusion ; 1 months; 3 months
|
Score at Clinician administered PTSD scale
|
inclusion ; 1 months; 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Score at PTSD Checklist (self-assessment)
Time Frame: inclusion ; 1 month; 3 months
|
Score at PTSD Checklist (self-assessment) for severity of PTSD
|
inclusion ; 1 month; 3 months
|
Change from baseline Score at PTSD Checklist (self-assessment) for different dimensions of PTSD
Time Frame: inclusion ; 1 month; 3 months
|
Score at PTSD Checklist (self-assessment) for severity of different dimensions of PTSD
|
inclusion ; 1 month; 3 months
|
Change from baseline Score at anxiety and depression item on Hamilton Anxiety Rating Scale (HAM-A)
Time Frame: inclusion ; 1 month; 3 months
|
Score at anxiety and depression item on Hamilton Anxiety Rating Scale (HAM-A)
|
inclusion ; 1 month; 3 months
|
Change from baseline Score at depression item on Hamilton Anxiety Rating Scale (HAM-A)
Time Frame: inclusion ; 1 month; 3 months
|
Score at depression item on Hamilton Depression Rating Scale (HAM-D)
|
inclusion ; 1 month; 3 months
|
Change from baseline heart rate
Time Frame: inclusion ; 1day ; 1 month, 3 months
|
heart rate
|
inclusion ; 1day ; 1 month, 3 months
|
Change from baseline electrodermal conductance
Time Frame: inclusion ; 1day ; 1 month, 3 months
|
electrodermal conductance measure
|
inclusion ; 1day ; 1 month, 3 months
|
Adverse effect
Time Frame: inclusion ; 1day ; 1 month, 3 months
|
Adverse effect
|
inclusion ; 1day ; 1 month, 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wissam EL-HAGE, PhD, Chru Tours
Publications and helpful links
General Publications
- Jaafari N, Rachid F, Rotge JY, Polosan M, El-Hage W, Belin D, Vibert N, Pelissolo A. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: a review. World J Biol Psychiatry. 2012 Mar;13(3):164-77. doi: 10.3109/15622975.2011.575177. Epub 2011 May 30.
- Quide Y, Witteveen AB, El-Hage W, Veltman DJ, Olff M. Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: a systematic review. Neurosci Biobehav Rev. 2012 Jan;36(1):626-44. doi: 10.1016/j.neubiorev.2011.09.004. Epub 2011 Sep 24.
- Tapia G, Clarys D, Bugaiska A, El-Hage W. Recollection of negative information in posttraumatic stress disorder. J Trauma Stress. 2012 Feb;25(1):120-3. doi: 10.1002/jts.21659. Epub 2012 Jan 25.
- Landre L, Destrieux C, Andersson F, Barantin L, Quide Y, Tapia G, Jaafari N, Clarys D, Gaillard P, Isingrini M, El-Hage W. Working memory processing of traumatic material in women with posttraumatic stress disorder. J Psychiatry Neurosci. 2012 Feb;37(2):87-94. doi: 10.1503/jpn.100167.
- Landre L, Destrieux C, Baudry M, Barantin L, Cottier JP, Martineau J, Hommet C, Isingrini M, Belzung C, Gaillard P, Camus V, El Hage W. Preserved subcortical volumes and cortical thickness in women with sexual abuse-related PTSD. Psychiatry Res. 2010 Sep 30;183(3):181-6. doi: 10.1016/j.pscychresns.2010.01.015. Epub 2010 Aug 4.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHAO 15- WEH / TETT- STIM
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress Disorders, Post-Traumatic
-
University of California, Los AngelesDefense Advanced Research Projects Agency; Defense Group, Inc.CompletedPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder, ChronicUnited States
-
Oregon Health and Science UniversityNational Center for Complementary and Integrative Health (NCCIH); Oregon Clinical...CompletedPost-Traumatic Stress DisordersUnited States
-
US Department of Veterans AffairsEmory UniversityWithdrawnPost-Traumatic Stress Disorders
-
University of KonstanzGerman Research Foundation; NGO vivo e.V.; GTZ-German Technical Cooperation,... and other collaboratorsCompletedPost-Traumatic Stress DisordersSri Lanka
-
Erkin Oğuz SARINot yet recruitingPost-Traumatic Stress DisorderTurkey
-
University Hospital, LilleNot yet recruiting
-
Steinn SteingrimssonRecruiting
-
Direction Centrale du Service de Santé des ArméesRecruitingPost-traumatic Stress DisorderFrance
-
VA Greater Los Angeles Healthcare SystemUniversity of California, Los AngelesRecruitingPost-Traumatic Stress DisorderUnited States
-
Johns Hopkins UniversityWithdrawnPost-Traumatic Stress Disorder
Clinical Trials on rTMS 1Hz
-
University of CalgaryCompletedStroke | Aphasia, Non-fluentCanada
-
Assiut UniversityCompletedObsessive Compulsive Disorders
-
University of CalgaryCompletedStroke | Aphasia, Non-fluentCanada
-
University of MinnesotaCompleted
-
Hospital de Clinicas de Porto AlegreCompletedSchizophrenia | Auditory HallucinationsBrazil
-
Centre Hospitalier St AnneCompletedDepersonalization DisorderFrance
-
Landspitali University HospitalNot yet recruitingNeglect, Hemispatial
-
Hospital Clinic of BarcelonaJohns Hopkins University; Imperial College London; Hospital Mutua de Terrassa; Universitat...RecruitingSystemic Lupus Erythematosus | Autoimmune Disorder | Vagus Nerve Autonomic DisorderSpain
-
NYU Langone HealthEnrolling by invitation
-
The First Hospital of Hebei Medical UniversityRecruitingHealthy Subjects | Transcranial Direct Current Stimulation | Motor Evoked PotentialChina